Low-dose heparin: Is the risk worth the benefit?

Rossman, 1974, True incidence of pulmonary embolization and vital statistics, J.A.M.A., 230, 1677, 10.1001/jama.1974.03240120045020 Coon, 1959, Deep vein thrombosis and pulmonary embolism, Am. J. cardiol., 4, 611, 10.1016/0002-9149(59)90145-6 Hume, 1970, Venous thrombosis and pulmonary embolism, 4 1973, Vol. 1, 10 Morrell, 1963, Pulmonary embolism, Br. Med. J., 2, 830, 10.1136/bmj.2.5361.830 1941 Coon, 1976, The spectrum of pulmonary embolism—twenty years later, Arch. Surg., 111, 398, 10.1001/archsurg.1976.01360220094015 Sherry, 1975, Low-dose heparin prophylaxis for postoperative venous thromboembolism, N. Engl. J. Med., 293, 300, 10.1056/NEJM197508072930612 Murray, 1936, Heparin and vascular occlusion, Can. Med. Assoc. J., 35, 621 Crafoord, 1937, Preliminary report on postoperative treatment with heparin as preventive of thrombosis, Acta Chir. Scand., 79, 407 Olovson, 1944, Blutjodstudien, Acta Clin. Scand., 90, 469 DeTakats, 1950, Anticoagulants in surgery, J.A.M.A., 142, 527, 10.1001/jama.1950.02910260001001 Bauer, 1954, 721 Lenggenhager, 1957, Genese und Prophylaxe der Post-operative Fern Thrombose, Helv. Clin. Acta, 24, 316 Sharnoff, 1966, Results in the prophylaxis of postoperative thromboembolism, Surg. Gynecol. Obstet., 123, 303 Contejean, 1895, Recherches sur les injections intraveineuses de peptone et leur influence sur la coagulabilite due san chez le chien, Arch. Physiol. Nor. Path., 7, 45 Brinkhous, 1939, The inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin, Am. J. Physiol., 125, 683, 10.1152/ajplegacy.1939.125.4.683 Yin, 1971, Identity of plasma activated Factor X inhibitor with antithrombin III and heparin cofactor, J. Biol. Chem., 246, 3712, 10.1016/S0021-9258(18)62185-4 Best, 1948, The known and unknown, 26 Seegers, 1962, Inhibition of autoprothrombin activity with plasma, Nature, 193, 1188, 10.1038/1931188b0 Davie, 1964, Waterfall sequence for intrinsic blood clotting, Science, 145, 1310, 10.1126/science.145.3638.1310 Macfarlane, 1964, An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier, Nature, 202, 498, 10.1038/202498a0 Barton, 1967, Relationships between Factor V and activated Factor X in the generation of prothrombinase, Nature, 214, 923, 10.1038/214923a0 Yin, 1968, Investigation of the apparent thrombogenicity of thrombin, Thromb. Diath. Haemorrh., 20, 465 Yin, 1970, Heparin-accelerated inhibition of activated Factor X by its natural inhibitor, Biochem. Biophys. Acta., 201, 387, 10.1016/0304-4165(70)90316-8 Rosenberg, 1977, Chemistry of the hemostatic mechanism and its relationship to the action of heparin, 36, 10 Gitel, 1977, In vitro and in vivo correlation of clotting protease activity: effect of heparin, 74, 3028 Markwordt, 1958, The reaction between hirudin and thrombin, Hoppe Seylers Z. Physiol. Chem., 312, 85, 10.1515/bchm2.1958.312.1.85 Henstell, 1967, The nature of heparin antithrombin action, Thromb. Diath. Haemorrh., 18, 167 Gitel, 1975, Evidence for a catalytic role of heparin in anticoagulation reactions, 243 Hirsh, 1975, Low-dose heparin in prophylaxis for venous thromboembolism, 183 1975, Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial, Lancet, 2, 45 Sagar, 1975, Low-dose heparin prophylaxis against fatal pulmonary embolism, Br. Med. J., 4, 257, 10.1136/bmj.4.5991.257 Pachter, 1977, Low-dose heparin: bleeding and wound complications in the surgical patient, Ann. Surg., 186, 669, 10.1097/00000658-197712000-00001 Strandness, D. E., Jr.: The case against low-dose heparin, in Current controversies in cardiovascular disease, Rapaport, E., ed., Philadelphia, W. B. Saunders, (In press). 1977, Prevention of venous thromboembolism in surgical patients by low-dose heparin, Circulation, 55, 423A Murray, 1970, Leg-vein thrombosis following myocardial infarction, Lancet, 2, 702 Maurer, 1971, Frequency of venous thrombosis after myocardial infarction, Lancet, 2, 1386 Nicolaides, 1971, Myocardial infarction and deep-vein prophylaxis, Br. Med. J., 1, 132, 10.1136/bmj.1.5746.432 Handley, 1972, Heparin in the prevention of deep venous thrombosis after myocardial infarction, Br. Med. J., 2, 436, 10.1136/bmj.2.5811.436 Handley, 1972, Low-dose heparin after myocardial infarction, Lancet, 2, 623, 10.1016/S0140-6736(72)93016-4 Gallus, 1973, Small subcutaneous doses of heparin in prevention of venous thrombosis, N. Engl. J. Med., 288, 545, 10.1056/NEJM197303152881103 Warlow, 1973, A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction, Lancet, 2, 934, 10.1016/S0140-6736(73)92597-X Habersberger, 1973, Venous thrombosis in myocardial infarction. Comparison in heparin dosage, Br. Heart J., 35, 538, 10.1136/hrt.35.5.538 Simmons, 1973, Deep venous thrombosis after myocardial infarction: predisposing factors, Br. Heart J., 35, 623, 10.1136/hrt.35.6.623 Pitney, 1974, The subcutaneous use of heparin in the prevention of venous thrombosis after myocardial infarction, Med. J. Australia, 1, 38, 10.5694/j.1326-5377.1974.tb50732.x Cristal, 1976, Identifying patients at risk for thromboembolism. Use of 125I-labeled fibrinogen in patients with acute myocardial infarction, J. A. M. A., 236, 2755, 10.1001/jama.1976.03270250023018 Emerson, 1977, Preventing thromboembolism after myocardial infarction: effect of low-dose heparin on smoking, Br. Med. J., 1, 18, 10.1136/bmj.1.6052.18 Russo, 1970, Heparin and ventricular arrhythmias after myocardial infarction, Lancet, 2, 1271, 10.1016/S0140-6736(70)92240-3 Rogers, 1975, Effects of heparin-induced free fatty acid elevation on cardiac metabolism, rhythm, and mechanical performance in patients with stable coronary artery disease, Clin. Res., 23, 206A Sharnoff, 1970, Prevention of fatal postoperative thromboembolism by heparin prophylaxis, Lancet, 2, 1006, 10.1016/S0140-6736(70)92815-1 Ferriar, 1810, Medical histories and reflections, Codell and Davies, London, 3, 169 Lobstein, 1833, 2, 610 Denham, 1972, The use of plasma 125I fibrinogen levels for the detection of deep venous thrombosis in geriatric patients, Age Ageing, 1, 245, 10.1093/ageing/1.4.245 Warlow, 1976, Deep venous thrombosis of the legs after strokes, Br. Med. J., 2, 1178, 10.1136/bmj.1.6019.1178 McCarthy, 1977, Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke, Lancet, 2, 800, 10.1016/S0140-6736(77)90728-0 Barnett, 1977, Safety of mini-dose heparin administration for neurosurgical patients, J. Neurosurg., 47, 27, 10.3171/jns.1977.47.1.0027 Harris, 1977, Heparin prophylaxis used in adults with respiratory distress, Am. Fam. Physician, 16, 214 Vessey, 1968, Investigation of relation between use of oral contraceptives and thromboembolism disease, Br. Med. J., 2, 199, 10.1136/bmj.2.5599.199 Sartwell, 1969, Thromboembolism and oral contraceptives: an epidemiology case-control study, Am. J. Epidemiol., 90, 365, 10.1093/oxfordjournals.aje.a121082 Vessey, 1969, Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report, Br. Med. J., 2, 651, 10.1136/bmj.2.5658.651 1973, oral contraception and increased risk of cerebral ischemia or thrombosis, N. Engl. J. Med., 288, 871, 10.1056/NEJM197304262881703 1975, Oral contraceptives and stroke in young women, J. A. M. A., 231, 718, 10.1001/jama.1975.03240190022010 Daniel, 1967, Puerperal thromboembolism and suppression of lactation, Lancet, 2, 287, 10.1016/S0140-6736(67)90117-1 1973, The coronary drug project. Findings leading to the discontinuation of the 2.5 mg./day estrogen groups, J.A.M.A., 226, 652, 10.1001/jama.1973.03230060030009 1967, Treatment and survival of patients with cancer of the prostate, Surg. Gynecol. Obstet., 124, 1011 Carter, 1977, Diethylstilbesterol: recommended dosages for different categories of breast cancer patients. Report of the cooperative breast cancer group, J. A. M. A., 237, 2079, 10.1001/jama.1977.03270460065023 Phillips, 1977, Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction, 74, 1729 Bailar, 1970, The Veterans Administration Cooperative Urological Research Group: Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbesterol and placebo, Cancer, 26, 257, 10.1002/1097-0142(197008)26:2<257::AID-CNCR2820260203>3.0.CO;2-9 Inman, 1970, Thromboembolic disease and the steroidal content of oral contraceptives: a report to the Committee on Safety of Drugs, Br. Med. J., 2, 203, 10.1136/bmj.2.5703.203 Vessey, 1970, Postoperative thromboembolism and the use of oral contraceptives, Br. Med. J., 3, 123, 10.1136/bmj.3.5715.123 Greene, 1972, Oral contraceptive use in patients with thromboembolism following surgery, trauma or infection, Am. J. Public Health, 62, 680, 10.2105/AJPH.62.5.680 Ory, 1977, Association between oral contraceptives and myocardial infarction. A review, J. A. M. A., 237, 2619, 10.1001/jama.1977.03270510041019 Gitel, 1978, The activated factor X-antithrombin III reaction rate: a measure of the increased thrombotic tendency induced by estrogen-containing oral contraceptives, Haemostasis, 7, 10 Wessler, 1976, Estrogen-containing oral contraceptive agents: a basis for their thrombogenicity, J. A. M. A., 236, 2179, 10.1001/jama.1976.03270200017021 Sagar, 1976, Oral contraceptives, antithrombin III activity, and postoperative deep-vein thrombosis, Lancet, 1, 509, 10.1016/S0140-6736(76)90296-8 Wessler, 1969, The role of stasis in thrombosis, 461 Kakkar, 1971, Prevention of postoperative deep vein thrombosis. Prophylactic effects of low doses of heparin, Lancet, 2, 699 Wessler, 1975, Biochemical rationale for mini-dose heparin in deep venous thrombosis, 177 Sharnoff, 1962, A plan of heparinization of the surgical patient to prevent post-operative thromboembolism, Surg. Gynecol. Obstet., 115, 75 Wessler, 1977, The anticoagulant dilemma—a prescription for its resolution, Am. J. Med. Sci., 274, 106, 10.1097/00000441-197709000-00001